Sampson, J. H., Gunn, M. D., Fecci, P. E. & Ashley, D. M. Brain immunology and immunotherapy in brain tumours. Nat. Rev. Cancer 20, 12–25 (2020).

Article  CAS  PubMed  Google Scholar 

Sampson, J. H., Maus, M. V. & June, C. H. Immunotherapy for brain tumors. J. Clin. Oncol. 35, 2450–2456 (2017).

Article  CAS  PubMed  Google Scholar 

Castellani, G., Croese, T., Peralta Ramos, J. M. & Schwartz, M. Transforming the understanding of brain immunity. Science 380, eabo7649 (2023).

Article  CAS  PubMed  Google Scholar 

Engelhardt, B., Vajkoczy, P. & Weller, R. O. The movers and shapers in immune privilege of the CNS. Nat. Immunol. 18, 123–131 (2017).

Article  CAS  PubMed  Google Scholar 

Herz, J., Filiano, A. J., Wiltbank, A. T., Yogev, N. & Kipnis, J. Myeloid cells in the central nervous system. Immunity 46, 943–956 (2017).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rustenhoven, J. et al. Functional characterization of the dural sinuses as a neuroimmune interface. Cell 184, 1000–1016.e27 (2021). This paper highlights that the dural meninges serve an integral role in CNS immune surveillance and can be implicated in neuroinflammatory and neurodegenerative states.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kolabas, Z. I. et al. Distinct molecular profiles of skull bone marrow in health and neurological disorders. Cell 186, 3706–3725.e29 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mazzitelli, J. A. et al. Skull bone marrow channels as immune gateways to the central nervous system. Nat. Neurosci. 26, 2052–2062 (2023).

Article  CAS  PubMed  Google Scholar 

Kloosterman, D. J. & Akkari, L. Macrophages at the interface of the co-evolving cancer ecosystem. Cell 186, 1627–1651 (2023).

Article  CAS  PubMed  Google Scholar 

Ott, M., Prins, R. M. & Heimberger, A. B. The immune landscape of common CNS malignancies: implications for immunotherapy. Nat. Rev. Clin. Oncol. 18, 729–744 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Paolicelli, R. C. et al. Microglia states and nomenclature: a field at its crossroads. Neuron 110, 3458–3483 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Salter, M. W. & Stevens, B. Microglia emerge as central players in brain disease. Nat. Med. 23, 1018–1027 (2017).

Article  CAS  PubMed  Google Scholar 

Ellwardt, E., Walsh, J. T., Kipnis, J. & Zipp, F. Understanding the role of T cells in CNS homeostasis. Trends Immunol. 37, 154–165 (2016).

Article  CAS  PubMed  Google Scholar 

Khanmammadova, N., Islam, S., Sharma, P. & Amit, M. Neuro-immune interactions and immuno-oncology. Trends Cancer 9, 636–649 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Salvador, A. F., de Lima, K. A. & Kipnis, J. Neuromodulation by the immune system: a focus on cytokines. Nat. Rev. Immunol. 21, 526–541 (2021).

Article  CAS  PubMed  Google Scholar 

Mancusi, R. & Monje, M. The neuroscience of cancer. Nature 618, 467–479 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zipp, F., Bittner, S. & Schafer, D. P. Cytokines as emerging regulators of central nervous system synapses. Immunity 56, 914–925 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Louveau, A. et al. Structural and functional features of central nervous system lymphatic vessels. Nature 523, 337–341 (2015). This study demonstrated that functional lymphatic vessels line the dural sinuses, carry immune cells from CSF, are connected to deep cervical lymph nodes, and can become dysfunctional in neuroinflammatory and neurodegenerative disorders.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pulous, F. E. et al. Cerebrospinal fluid can exit into the skull bone marrow and instruct cranial hematopoiesis in mice with bacterial meningitis. Nat. Neurosci. 25, 567–576 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mazzitelli, J. A. et al. Cerebrospinal fluid regulates skull bone marrow niches via direct access through dural channels. Nat. Neurosci. 25, 555–560 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brown, C. E. et al. Stem-like tumor-initiating cells isolated from IL13Rα2 expressing gliomas are targeted and killed by IL13-zetakine-redirected T cells. Clin. Cancer Res.18, 2199–2209 (2012).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Flores, C. et al. Massive clonal expansion of medulloblastoma-specific T cells during adoptive cellular therapy. Sci. Adv. 5, eaav9879 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Murad, S. et al. NKG2C+ NK cells for immunotherapy of glioblastoma multiforme. Int. J. Mol. Sci. 23, 5857 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reardon, D. A. et al. Glioblastoma eradication following immune checkpoint blockade in an orthotopic, immunocompetent model. Cancer Immunol. Res. 4, 124–135 (2016).

Article  CAS  PubMed  Google Scholar 

Monje, M. et al. Roadmap for the emerging field of cancer neuroscience. Cell 181, 219–222 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Winkler, F. et al. Cancer neuroscience: state of the field, emerging directions. Cell 186, 1689–1707 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Taylor, B. C. & Balko, J. M. Mechanisms of MHC-I downregulation and role in immunotherapy response. Front. Immunol. 13, 844866 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Harrison, A. J. et al. Enhancing co-stimulation of CAR T cells to improve treatment outcomes in solid cancers. Immunother. Adv. 1, ltab016 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Traylor, T. D. & Hogan, E. L. Gangliosides of human cerebral astrocytomas. J. Neurochem. 34, 126–131 (1980).

Article  CAS  PubMed  Google Scholar 

Shen, L. et al. The efficacy of third generation anti-HER2 chimeric antigen receptor T cells in combination with PD1 blockade against malignant glioblastoma cells. Oncol. Rep. 42, 1549–1557 (2019).

CAS  PubMed